Analysts at Lake Street Capital initiated coverage on shares of Anteris Technologies Global (NASDAQ:AVR – Get Free Report) in a note issued to investors on Wednesday, MarketBeat reports. The brokerage set a “buy” rating and a $20.00 price target on the stock. Lake Street Capital’s price objective would indicate a potential upside of 255.24% from the stock’s current price.
Several other brokerages also recently weighed in on AVR. TD Cowen initiated coverage on Anteris Technologies Global in a research note on Tuesday. They set a “buy” rating and a $15.00 target price for the company. Barclays initiated coverage on Anteris Technologies Global in a research note on Tuesday. They set an “overweight” rating and a $22.00 target price for the company. Finally, Cantor Fitzgerald initiated coverage on Anteris Technologies Global in a research note on Tuesday. They set an “overweight” rating and a $9.00 target price for the company.
Read Our Latest Stock Analysis on Anteris Technologies Global
Anteris Technologies Global Stock Performance
About Anteris Technologies Global
Anteris Technologies Global Corp. engages in the development and commercialization of medical devices for heart diseases. The company was founded in 1999 and is headquartered in Eagan, MN.
Featured Articles
- Five stocks we like better than Anteris Technologies Global
- How Can Retail Investors Trade the Toronto Stock Exchange (TSX)?
- MercadoLibre: Latin America’s Digital Titan Just Got Cheaper
- What does consumer price index measure?
- Breaking Down Pegasystems, A Wedbush Top AI Pick for 2025
- How to Invest in Blue Chip Stocks
- Shutterstock and Getty: A $3.7 Billion Visual Content Giant
Receive News & Ratings for Anteris Technologies Global Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Anteris Technologies Global and related companies with MarketBeat.com's FREE daily email newsletter.
